Close Menu

NEW YORK (GenomeWeb) – Singapore-based cancer detection firm Ark said today that it has raised $40 million in a Series A investment led by shareholders of Venturecraft and backed by Gaorong Capital (formerly Banyan Capital).

The company is the result of a merger between Venturecraft and MiRxes, a technology firm that was spun out of Singapore's Agency for Science, Technology and Research (A*STAR) in 2014.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Economist reports that it is increasingly easier to analyze the metabolites people give off, potentially revealing personal information about them.

A controversial paper on the gender gap in science has been corrected, according to BuzzFeed News.

The Los Angeles Times reports that only a third of California students meet the state's new science standards.

In Science this week: evidence of interbreeding between the ancestors of West Africans and an unknown archaic human, and more.